Strokes and their complications are major clinical and social problems. Stroke diagnosis is limited to clinical and imaging evaluation –
mainly by computed tomography (CT), which is particularly low sensitive to early ischemic stroke. Due to diagnostic problems, there are
many studies conducted to find a laboratory marker of stroke, which can play similar role to troponins in the diagnosis of acute coronary
syndrome. The aim of this article is to review scientific research in which the usefulness of potential stroke markers was assessed. Among
analyzed parameters there are: inflammatory mediators (CRP, IL-1, IL-6, TNF– α, MCP-1, MMP-9), neural tissue markers (S100B protein,
NSE, GFAP), coagulation and fibrinolysis components (vWF, D-dimer) and other markers – BNP, NT-proBNP, and osteoprotegerin. Some
studies show the potential of laboratory markers in the differential diagnosis of the type of stroke, predicting the risk of mortality, or in
patient’s condition assessment but yet none of the markers fulfill the criteria of a diagnostic test in stroke.